Adenylosuccinate Lyase Deficiency (dADSL)

last updated: Jun 2013

Patient	Family	Gender	Country	Mutation cDNA (list)	Mutation protein (list)	Location in protein	Phenotype	SAdo (CSF) μmol/l	SAICAr (CSF) μmol/l	SAdo/ SAICAr (CSF)
1 [1;12]	1	F	AU	c.-49T>C	xxx	xxx	severe	4.9^a,f	6.9^a,f	0.7^a
1 [1;12]	1	F	AU	c.953C>T	p.P318L	Central helical region	severe	4.9^a,f	6.9^a,f	0.7^a
2 [1;2;3]	2	F	IT	c.-49T>C	xxx	xxx	severe	158	167	0.9
2 [1;2;3]	2	F	IT	c.1277G>A	p.R426H	Substrate channel	severe	158	167	0.9
3 [1]	3		NO	c.-49T>C	xxx	xxx	severe			n.d.^c
3 [1]	3		NO	?	p.S447P	Substrate channel	severe			n.d.^c
4 [3;4;5]	4	M	DE	c.421C>T	p.R141W	Central helical region	neonatal	470^d	320^d	1.5
4 [3;4;5]	4	M	DE	c.618C>A	p.206-218del	xxx	neonatal	470^d	320^d	1.5
5 [6]	5	F	FR	c.1A>C	p.M1L	not assigned	severe	367	376	1
5 [6]	5	F	FR	c.1120C>T	p.R374W	Substrate channel	severe	367	376	1
6 [7]	6	F	US	c.1A>G	p.M1V	not assigned	mild	87^a,d	58^a,d	1.5^a
6 [7]	6	F	US	c.1342T>C	p.S448P	Substrate channel	mild	87^a,d	58^a,d	1.5^a
7 [5;8]	7	M	NL	c.5C>T	p.A2V	not assigned	neonatal	1-2^e	1-2^e	1
7 [5;8]	7	M	NL	?	p.S395R	Substrate channel	neonatal	1-2^e	1-2^e	1
8 [9]	8	F	GB	c.7G>C	p.A3P	not assigned	neonatal	477	921	0.5
8 [9]	8	F	GB	c.568C>T	p.R190X	xxx	neonatal	477	921	0.5
9 [10]	9	F	CZ	c.8C>T	p.A3V	not assigned	severe	126	147	0.9
9 [10]	9	F	CZ	c.1009C>T	p.R337X	xxx	severe	126	147	0.9
10 [–]	10	F	PL	c.8C>T	p.A3V	not assigned	severe	338^a,d	323^a,d	1.0^a
10 [–]	10	F	PL	lack of mRNA	lack of mRNA	xxx	severe	338^a,d	323^a,d	1.0^a
11 [11]	11	M	PL	c.69C>G	p.S23R	Central helical region / Active site	severe	311	374	0.8
11 [11]	11	M	PL	c.1277G>A	p.R426H	Substrate channel	severe	311	374	0.8
12 [3;4;5]	12	M	DE	?	p.M26L	Central helical region / Active site	severe	370^a,d	400^a,d	0.9^a
12 [3;4;5]	12	M	DE	c.1277G>A	p.R426H	Substrate channel	severe	370^a,d	400^a,d	0.9^a
13 [5]	13		BE	c.214A>G	p.I72V	Substrate channel	severe			n.d.^c
13 [5]	13		BE	c.736A>G	p.K246E	Subunit interface	severe			n.d.^c
14 [12;22]	14	M	AU	c.240A>C	p.E80D	Active site	mild	1.89^a,f	0.87^a,f	2.4^a
14 [12;22]	14	M	AU	c.261T>G	p.D87E	Active site	mild	1.89^a,f	0.87^a,f	2.4^a
15 [13]	15	F	IT	c.298C>G	p.P100A	Substrate channel	severe	75	60	1.3
15 [13]	15	F	IT	c.1264G>T	p.D422Y	Substrate channel	severe	75	60	1.3
16 [10]	16	M	CZ	c.340T>C	p.Y114H	Active site	mild	283	127	2.2
16 [10]	16	M	CZ	c.569G>A	p.R190Q	Central helical region	mild	283	127	2.2
17 [10]	16	F	CZ	c.340T>C	p.Y114H	Active site	mild	260	125	2.1
17 [10]	16	F	CZ	c.569G>A	p.R190Q	Central helical region	mild	260	125	2.1
18 [11]	17	F	PL	c.340T>C	p.Y114H	Active site	neonatal			n.d.^c
18 [11]	17	F	PL	c.725C>T	p.T242I	Active site	neonatal			n.d.^c
19 [11]	17	F	PL	c.340T>C	p.Y114H	Active site	severe	562	599	0.9
19 [11]	17	F	PL	c.725C>T	p.T242I	Active site	severe	562	599	0.9
20 [14]	18	M	CZ	c.340T>C	p.Y114H	Active site	neonatal	684	1100	0.6
20 [14]	18	M	CZ	c.1128G>C	p.E376D	Active site / Subunit interface	neonatal	684	1100	0.6
21 [7]	19	M	CZ	c.340T>C	p.Y114H	Active site	severe	649	953	0.7
21 [7]	19	M	CZ	c.1187G>A	p.R396H	Substrate channel	severe	649	953	0.7
22 [14]	20	M	DE	c.340T>C	p.Y114H	Active site	neonatal			1.1^a
22 [14]	20	M	DE	c.1277G>A	p.R426H	Substrate channel	neonatal			1.1^a
23 [14]	20	M	DE	c.340T>C	p.Y114H	Active site	neonatal			n.d.^c
23 [14]	20	M	DE	c.1277G>A	p.R426H	Substrate channel	neonatal			n.d.^c
24 [14]	20	M	DE	c.340T>C	p.Y114H	Active site	neonatal			n.d.^c
24 [14]	20	M	DE	c.1277G>A	p.R426H	Substrate channel	neonatal			n.d.^c
25 [14]	21	F	CZ	c.340T>C	p.Y114H	Active site	neonatal	169	330	0.5
25 [14]	21	F	CZ	c.1277G>A	p.R426H	Substrate channel	neonatal	169	330	0.5
26 [–]	22	M	CZ	c.340T>C	p.Y114H	Active site	neonatal			1.1^a
26 [–]	22	M	CZ	c.1277G>A	p.R426H	Substrate channel	neonatal			1.1^a
27 [25]	23	M	MY	c.445C>G	p.R149G		severe	380^a,d	370^a,d	1.02^a
27 [25]	23	M	MY	c.774_778insG	p.A260GfsX24		severe	380^a,d	370^a,d	1.02^a
28 [5;15]	24	F	BE	c.569G>A	p.R190Q	Central helical region	moderate	379	214	1.8
28 [5;15]	24	F	BE	c.736A>G	p.K246E	Subunit interface	moderate	379	214	1.8
29 [10]	25	F	CZ	c.580C>T	p.R194C	Subunit interface	severe	269	281	1
29 [10]	25	F	CZ	c.802G>A	p.D268N	Active site	severe	269	281	1
30 [14]	26		DE	c.580C>T	p.R194C	Subunit interface	neonatal
30 [14]	26		DE	c.1186C>T	p.R396C	Substrate channel	neonatal
31 [11]	27	F	PL	c.643G>C	p.D215H	Substrate channel	severe	290^a,d	215^a,d	1.3^a
31 [11]	27	F	PL	c.1052T>C	p.I351T	Central helical region / Active site	severe	290^a,d	215^a,d	1.3^a
32 [16]	28	F	MA	c.674T>C	p.M225T	Substrate channel	severe	101^a,d	63^a,d	1.6^a
32 [16]	28	F	MA	c.674T>C	p.M225T	Substrate channel	severe	101^a,d	63^a,d	1.6^a
33 [16]	28	F	MA	c.674T>C	p.M225T	Substrate channel	severe	79^a,d	49^a,d	1.6^a
33 [16]	28	F	MA	c.674T>C	p.M225T	Substrate channel	severe	79^a,d	49^a,d	1.6^a
34 [11]	29	F	PL	c.802G>C	p.D268H	Active site	mild	1816^a,d	896^a,d	2.1^a
34 [11]	29	F	PL	c.1277G>A	p.R426H	Substrate channel	mild	1816^a,d	896^a,d	2.1^a
35 [7]	30	M	US	c.802G>A	p.D268N	Active site	severe
35 [7]	30	M	US	c.1400C>G	p.P467R	Central helical region	severe
36 [26]	31		NL		p.N297S		mild to severe	370	210	1.8
36 [26]	31		NL	c.907C>T	p.R303C	Active site	mild to severe	370	210	1.8
37 [26]	32		NL		p.N297S		mild	1130	390	2.1
37 [26]	32		NL	c.907C>T	p.R303C	Active site	mild	1130	390	2.1
38 [3;5;17]	33	F	NL	c.907C>T	p.R303C	Active site	mild			4
38 [3;5;17]	33	F	NL	c.907C>T	p.R303C	Active site	mild			4
39 [3;7]	34		?	c.907C>T	p.R303C	Active site	mild			3
39 [3;7]	34		?	c.907C>T	p.R303C	Active site	mild			3
40 [18]	35	F	ES	c.931C>G	p.L311V	Central helical region	severe	273	180	1.5
40 [18]	35	F	ES	c.1187G>A	p.R396H	Substrate channel	severe	273	180	1.5
41 [18]	36	F	ES	c.1090G>A	p.V364M	Substrate channel / Central helical region	severe	5^b	2.8^b	1.8^b
41 [18]	36	F	ES	c.1355G>C	p.R452P	Substrate channel	severe	5^b	2.8^b	1.8^b
42 [18]	36	F	ES	c.1090G>A	p.V364M	Substrate channel / Central helical region	severe	359	228	1.6
42 [18]	36	F	ES	c.1355G>C	p.R452P	Substrate channel	severe	359	228	1.6
43 [24]	37		ES	c.1107A>C	p.I369L	Active site / Substrate channel	severe			1.9^a
43 [24]	37		ES	c.1107A>C	p.I369L	Active site / Substrate channel	severe			1.9^a
44 [adsldb]	38		?	c.1267C>G	p.L423V	Substrate channel	moderate			n.d.^c
44 [adsldb]	38		?	c.1277G>A	p.R426H	Substrate channel	moderate			n.d.^c
45 [7]	39	M	DE	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
45 [7]	39	M	DE	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
46 [3;17]	40		BE	c.1277G>A	p.R426H	Substrate channel	severe			1.3
46 [3;17]	40		BE	c.1277G>A	p.R426H	Substrate channel	severe			1.3
47 [11]	41	F	PL	c.1277G>A	p.R426H	Substrate channel	moderate	198^a,d	133^a,d	1.5^a
47 [11]	41	F	PL	c.1277G>A	p.R426H	Substrate channel	moderate	198^a,d	133^a,d	1.5^a
48 [11]	42	F	PL	c.1277G>A	p.R426H	Substrate channel	moderate	210^a,d	125^a,d	1.7^a
48 [11]	42	F	PL	c.1277G>A	p.R426H	Substrate channel	moderate	210^a,d	125^a,d	1.7^a
49 [5;19]	43	F	NL	c.1277G>A	p.R426H	Substrate channel	severe			1
49 [5;19]	43	F	NL	c.1277G>A	p.R426H	Substrate channel	severe			1
50 [5]	44		NL	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
50 [5]	44		NL	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
51 [adsldb]	45		NL	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
51 [adsldb]	45		NL	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
52 [20]	46	M	PT	c.1277G>A	p.R426H	Substrate channel	severe	271	173	1.6
52 [20]	46	M	PT	c.1277G>A	p.R426H	Substrate channel	severe	271	173	1.6
53 [20]	46	M	PT	c.1277G>A	p.R426H	Substrate channel	severe	178	132	1.4
53 [20]	46	M	PT	c.1277G>A	p.R426H	Substrate channel	severe	178	132	1.4
54 [3]	47		NL	c.1277G>A	p.R426H	Substrate channel	severe			1.2
54 [3]	47		NL	c.1277G>A	p.R426H	Substrate channel	severe			1.2
55 [10]	48	M	CZ	c.1277G>A	p.R426H	Substrate channel	severe			1.2
55 [10]	48	M	CZ	c.1277G>A	p.R426H	Substrate channel	severe			1.2
56 [adsldb]	49		TR	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
56 [adsldb]	49		TR	c.1277G>A	p.R426H	Substrate channel	severe			n.d.^c
57 [20]	50	F	PT	c.1277G>A	p.R426H	Substrate channel	severe	242	197	1.2
57 [20]	50	F	PT	c.1277G>A	p.R426H	Substrate channel	severe	242	197	1.2
58 [3]	51	F	NL	c.1277G>A	p.R426H	Substrate channel	severe			1.5
58 [3]	51	F	NL	c.1277G>A	p.R426H	Substrate channel	severe			1.5
59 [26]	52		DE	c.1277G>A	p.R426H	Substrate channel	severe	292	207	1.4
59 [26]	52		DE	c.1277G>A	p.R426H	Substrate channel	severe	292	207	1.4
60 [10]	53	F	US	c.1277G>A	p.R426H	Substrate channel	mild			2.6
60 [10]	53	F	US	c.1288G>A	p.D430N	Substrate channel	mild			2.6
61 [3]	54	F	NL	c.1277G>A	p.R426H	Substrate channel	moderate			2.5
61 [3]	54	F	NL	c.1349C>G	p.T450S	Substrate channel	moderate			2.5
62 [adsldb]	54	M	NL	c.1277G>A	p.R426H	Substrate channel	moderate			n.d.^c
62 [adsldb]	54	M	NL	c.1349C>G	p.T450S	Substrate channel	moderate			n.d.^c
63 [21;23]	55	F	MA	c.1312T>C	p.S438P	Substrate channel	severe			1.5
63 [21;23]	55	F	MA	c.1312T>C	p.S438P	Substrate channel	severe			1.5
64 [21;23]	55	M	MA	c.1312T>C	p.S438P	Substrate channel	severe			1.1
64 [21;23]	55	M	MA	c.1312T>C	p.S438P	Substrate channel	severe			1.1
65 [18]	56	M	CO	n.d.^c	n.d.^c		neonatal	160	164	1
66 [18]	56	M	CO	n.d.^c	n.d.^c		neonatal
67 [–]	57	F	US	c.1277G>A	p.R426H	Substrate channel	mild to severe	222		n.d.^c
67 [–]	57	F	US	c.1277G>A	p.R426H	Substrate channel	mild to severe	222		n.d.^c
68 [–]	57	F	US	n.d.^c	n.d.^c	Substrate channel	mild to severe	430		n.d.^c
69 [27]	58	M	GB	c.-49T>C	n.d.^c		severe	362^a	401^a	1
69 [27]	58	M	GB	c.1277G>A	p.R426H		severe	362^a	401^a	1
70 [27]	59	M	GB	c.421C>T	p.R141W		severe	2030^a	1314^a	1.6
70 [27]	59	M	GB	c.1304C>T	p.P435L		severe	2030^a	1314^a	1.6
71 [–]	60	M	DE	c.731C>T	p.T244I		moderate	440^a,d		n.d.^c
71 [–]	60	M	DE	1191+5G>C	splice		moderate	440^a,d		n.d.^c
72 [28]	61	M	DO	c.1107A>C	p.I369L		severe			1.88^a
72 [28]	61	M	DO	c.1107A>C	p.I369L		severe			1.88^a
73 [28]	62	F	ES	c.1165A>G	p.M389V		mild			3.41^a
73 [28]	62	F	ES	c.1165A>G	p.I389V		mild			3.41^a
74 [28]	63	M	ES	c.1165A>G	p.M389V		mild to severe			2.70^a
74 [28]	63	M	ES	c.1165A>G	p.I389V		mild to severe			2.70^a
75 [–]	64	M	US	1277G>A	R426H		mild
75 [–]	64	M	US	1277G>A	R426H		mild
76 [–]	64	M	US	1277G>A	R426H		mild
76 [–]	64	M	US	1277G>A	R426H		mild

^a … in urine ^b … in plasma ^c … not determined ^d … mmol/mol creat. ^e … mmol/l ^f … μmol/mg creat.

CSF … cerebrospinal fluid

[1] Marie S, Race V, Nassogne MC, Vincent MF, Van den Berghe G. 2002. Mutation of a nuclear respiratory factor 2 binding site in the 5 untranslated region of the ADSL gene in three patients with adenylosuccinate lyase deficiency. Am J Hum Genet 71(1):14-21. [abstract]

[2] Nassogne M, Henrot B, Aubert G, Bonnier C, Marie S, Saint-Martin C, Van den Berghe G, Sebire G, Vincent M. 2000. Adenylosuccinase deficiency: an unusual cause of early-onset epilepsy associated with acquired microcephaly. Brain Dev 22(6):383-6.[abstract]

[3] Race V, Marie S, Vincent MF, Van Den Berghe G. 2000. Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency. Hum Mol Genet 9(14):2159-65. [abstract]

[4] Kohler M, Assmann B, Brautigam C, Storm W, Marie S, Vincent MF, Van den Berghe G, Simmonds HA, Hoffmann GF. 1999. Adenylosuccinase deficiency: possibly underdiagnosed encephalopathy with variable clinical features. Eur J Paediatr Neurol 3(1):3-6. [abstract]

[5] Marie S, Cuppens H, Heuterspreute M, Jaspers M, Tola EZ, Gu XX, Legius E, Vincent MF, Jaeken J, Cassiman JJ and others. 1999. Mutation analysis in adenylosuccinate lyase deficiency: eight novel mutations in the re-evaluated full ADSL coding sequence. Hum Mutat 13(3):197-202. [abstract]

[6] Holder-Espinasse M, Marie S, Bourrouillou G, Ceballos-Picot I, Nassogne MC, Faivre L, Amiel J, Munnich A, Vincent MF, Cormier-Daire V. 2002. Towards a suggestive facial dysmorphism in adenylosuccinate lyase deficiency? J Med Genet 39(6):440-2. [article]

[7] Spiegel EK, Colman RF, Patterson D. 2006. Adenylosuccinate lyase deficiency. Mol Genet Metab 89(1-2):19-31. [abstract]

[8] van den Bergh FA, Bosschaart AN, Hageman G, Duran M, Tien Poll-The B. 1998. Adenylosuccinase deficiency with neonatal onset severe epileptic seizures and sudden death. Neuropediatrics 29(1):51-3. [abstract]

[9] Marinaki AM, Champion M, Kurian MA, Simmonds HA, Marie S, Vincent MF, van den Berghe G, Duley JA, Fairbanks LD. 2004. Adenylosuccinate lyase deficiency-first British case. Nucleosides Nucleotides Nucleic Acids 23(8-9):1231-3. [abstract]

[10] Kmoch S, Hartmannova H, Stiburkova B, Krijt J, Zikanova M, Sebesta I. 2000. Human adenylosuccinate lyase (ADSL), cloning and characterization of full-length cDNA and its isoform, gene structure and molecular basis for ADSL deficiency in six patients. Hum Mol Genet 9(10):1501-13. [abstract]

[11] Jurecka A, Zikanova M, Tylki-Szymanska A, Krijt J, Bogdanska A, Gradowska W, Mullerova K, Sykut-Cegielska J, Kmoch S, Pronicka E. 2008. Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency. Mol Genet Metab 94(4):435-42. [abstract]

[12] Stathis SL, Cowley DM, Broe DB. 2000. Autism and Adenylosuccinase deficiency. J Am Acad Child Adolesc Psychiatry 39(3):274-275.[abstract]

[13] Verginelli D, Luckow B, Crifo C, Salerno C, Gross M. 1998. Identification of new mutations in the adenylosuccinate lyase gene associated with impaired enzyme activity in lymphocytes and red blood cells. Biochim Biophys Acta 1406(1):81-4. [abstract]

[14] Mouchegh K, Zikanova M., Hoffmann, G. F., Kretzschmar, B., Kuhn, T., Mildenberger, E., Stoltenburg-Didinger, G., Krijt, J., Dvorakova, L., Honzik, T., Zeman, J., Kmoch, S., Rossi, R. 2007. Lethal fetal and early neonatal presentation of adenylosuccinate lyase deficiency: observation of 6 patients in 4 families. J Pediatr 150(1):57-61 e2. [abstract]

[15] Jaeken J, Van den Bergh F, Vincent MF, Casaer P, Van den Berghe G. 1992. Adenylosuccinase deficiency: a newly recognized variant. J Inherit Metab Dis 15(3):416-8. [article]

[16] Gitiaux C, Ceballos-Picot I, Marie S, Valayannopoulos V, Rio M, Verrieres S, Benoist JF, Vincent MF, Desguerre I, Bahi-Buisson N. 2009. Misleading behavioural phenotype with adenylosuccinate lyase deficiency. Eur J Hum Genet 17(1):133-6. [abstract]

[17] Jaeken J, Wadman SK, Duran M, van Sprang FJ, Beemer FA, Holl RA, Theunissen PM, de Cock P, van den Bergh F, Vincent MF and others. 1988. Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr 148(2):126-31. [article]

[18] Castro M, Perez-Cerda C, Merinero B, Garcia MJ, Bernar J, Gil Nagel A, Torres J, Bermudez M, Garavito P, Marie S and others. 2002. Screening for adenylosuccinate lyase deficiency: clinical, biochemical and molecular findings in four patients. Neuropediatrics 33(4):186-9. [abstract]

[19] Maaswinkel-Mooij PD, Laan LA, Onkenhout W, Brouwer OF, Jaeken J, Poorthuis BJ. 1997. Adenylosuccinase deficiency presenting with epilepsy in early infancy. J Inherit Metab Dis 20(4):606-7. [article]

[20] Edery P, Chabrier S, Ceballos-Picot I, Marie S, Vincent MF, Tardieu M. 2003. Intrafamilial variability in the phenotypic expression of adenylosuccinate lyase deficiency: a report on three patients. Am J Med Genet A 120(2):185-90. [abstract]

[21] Stone RL, Aimi J, Barshop BA, Jaeken J, Van den Berghe G, Zalkin H, Dixon JE. 1992. A mutation in adenylosuccinate lyase associated with mental retardation and autistic features. Nat Genet 1(1):59-63. [abstract]

[22] Silvedran S, Patterson et al. 2004. Two novel mutant human adenylosuccinate lyases (ASLs) associated with autism and characterization of the equivalent mutant Bacillus subtilis ASL. J Biol Chem 279(51):53789-97. [abstract]

[23] Jaeken J, Van der Berghe G. 1984. An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. The Lancet, Nov 10, 1058-61. [abstract]

[24] Sempere, A., et al., (2010) J Inherit Metab Dis; Study of inborn errors of metabolism in urine from patients with unexplained mental retardation. [abstract]

[25] Chen BC, McGown IN, Thong MK, Pitt J, Yunus ZM, Khoo TB, Ngu LH, Duley JA 2010. Adenylosuccinate lyase deficiency in a Malaysian patient, with novel adenylosuccinate lyase gene mutations. J Inherit Metab Dis. 2010 Feb 23. [abstract]

[26] Henneke M, Dreha-Kulaczewski S, Brockmann K, van der Graaf M, Willemsen MA, Engelke U, Dechent P, Heerschap A, Helms G, Wevers RA, Gärtner J. In vivo proton MR spectroscopy findings specific for adenylosuccinate lyase deficiency. NMR Biomed. 2010 Feb 19. [abstract]

[27] Lundy CT, Jungbluth H, Pohl KR, Siddiqui A, Marinaki AM, Mundy H, Champion MP. (2010) Adenylosuccinate lyase deficiency in the United Kingdom pediatric population: first three cases. Pediatr Neurol 43(5):351-4. [abstract]

[28] Perez-Duenas B, Sempere A, Campistol J, Alonso-Colmenero I, Diez M, Gonzalez V, Merinero B, Desviat LR, Artuch R. 2012. Novel features in the evolution of adenylosuccinate lyase deficiency. Eur J Paediatr Neurol 16(4):343-8. [abstract]

back to the top